Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| ACHV | NASDAQ | Achieve Life Sciences, Inc. | $6.54 | +0.77% | 702K | $672.98M |
| OABI | NASDAQ | OmniAb, Inc. | $4.61 | -1.07% | 972K | $670.25M |
| IMMX | NASDAQ | Immix Biopharma, Inc. | $8.06 | -1.10% | 1.1M | $668.2M |
| PRME | NASDAQ | Prime Medicine, Inc. | $3.61 | -1.63% | 2.5M | $654.77M |
| DSGN | NASDAQ | Design Therapeutics, Inc. | $10.34 | +0.98% | 317K | $647.09M |
| LXRX | NASDAQ | Lexicon Pharmaceuticals, Inc. | $1.45 | +2.11% | 2.2M | $645.19M |
| GYRE | NASDAQ | Gyre Therapeutics, Inc. | $6.07 | +3.76% | 93K | $643.63M |
| HELP | NASDAQ | Helus Pharma Inc. | $10.36 | +1.67% | 1M | $642.16M |
| AURA | NASDAQ | Aura Biosciences, Inc. | $6.18 | -1.90% | 844K | $640.9M |
| SOPH | NASDAQ | SOPHiA GENETICS S.A. | $7.52 | +2.31% | 261K | $640.16M |
| ATTO | NASDAQ | Attovia Therapeutics, Inc. | $13.88 | +0.36% | 225K | $633.64M |
| WVE | NASDAQ | Wave Life Sciences Ltd. | $3.21 | +0.94% | 3.2M | $632.52M |
| STLN | NASDAQ | Starling Oncology, Inc. | $6.29 | -6.26% | 1.9M | $628.89M |
| KIDS | NASDAQ | OrthoPediatrics Corp. | $24.02 | -1.96% | 378K | $627.16M |
| SLDB | NASDAQ | Solid Biosciences Inc. | $5.81 | -1.86% | 1.1M | $622.98M |
| CRMD | NASDAQ | CorMedix Inc. | $7.94 | +1.15% | 1.1M | $618.88M |
| FDMT | NASDAQ | 4D Molecular Therapeutics, Inc. | $11.03 | +2.13% | 1.1M | $609.34M |
| ANNX | NASDAQ | Annexon, Inc. | $3.70 | -1.33% | 2.6M | $606.22M |
| NVCT | NASDAQ | Nuvectis Pharma, Inc. | $18.49 | -7.78% | 319K | $603.59M |
| CADL | NASDAQ | Candel Therapeutics, Inc. | $7.79 | -2.99% | 848K | $596.08M |
| OLMA | NASDAQ | Olema Pharmaceuticals, Inc. | $6.62 | +3.28% | 2M | $579.23M |
| IRWD | NASDAQ | Ironwood Pharmaceuticals, Inc. | $3.50 | +1.16% | 1.1M | $578.34M |
| MYGN | NASDAQ | Myriad Genetics, Inc. | $6.02 | +3.44% | 1.5M | $575.81M |
| ZVRA | NASDAQ | Zevra Therapeutics, Inc. | $9.53 | -2.85% | 722K | $565.93M |
| AVR | NASDAQ | Anteris Technologies Global Corp. | $5.78 | -1.53% | 739K | $563.31M |
| ANL | NASDAQ | Adlai Nortye Ltd. | $10.58 | +0.19% | 133K | $561.59M |
| MDXG | NASDAQ | MiMedx Group, Inc. | $3.85 | -1.53% | 1.1M | $561.18M |
| PBYI | NASDAQ | Puma Biotechnology, Inc. | $10.85 | -1.54% | 356K | $560.08M |
| ACRS | NASDAQ | Aclaris Therapeutics, Inc. | $3.79 | +1.07% | 1.6M | $557.88M |
| FLGT | NASDAQ | Fulgent Genetics, Inc. | $20.22 | +0.60% | 191K | $556.36M |
| STTK | NASDAQ | Shattuck Labs, Inc. | $5.54 | +0.91% | 706K | $556.01M |
| EVO | NASDAQ | Evotec SE | $1.52 | +1.33% | 121K | $539.88M |
| TCMD | NASDAQ | Tactile Systems Technology, Inc. | $23.39 | -1.06% | 162K | $529.84M |
| ANGO | NASDAQ | AngioDynamics, Inc. | $12.17 | -1.58% | 459K | $511.8M |
| VALN | NASDAQ | Valneva SE | $5.41 | +2.85% | 21K | $508.91M |
| CLYM | NASDAQ | Climb Bio, Inc. | $8.81 | -13.54% | 3.4M | $506.01M |
| DRUG | NASDAQ | Bright Minds Biosciences Inc. | $51.09 | -2.65% | 89K | $503.95M |
| DCTH | NASDAQ | Delcath Systems, Inc. | $14.51 | +0.62% | 233K | $503.48M |
| AQST | NASDAQ | Aquestive Therapeutics, Inc. | $3.97 | -0.75% | 1.3M | $498.28M |
| ENTX | NASDAQ | Entera Bio Ltd. | $2.86 | -2.05% | 232K | $497.17M |
| SGHT | NASDAQ | Sight Sciences, Inc. | $9.02 | +0.33% | 268K | $496.89M |
| NRC | NASDAQ | NRC Health | $22.45 | +2.37% | 94K | $496.59M |
| MMEDV | NASDAQ | MiniMed Group, Inc. | $17.70 | +1.17% | 227K | $495.6M |
| OCS | NASDAQ | Oculis Holding AG | $7.96 | +0.76% | 207K | $490.24M |
| CTMX | NASDAQ | CytomX Therapeutics, Inc. | $2.23 | -4.09% | 5.2M | $484.83M |
| MASS | NASDAQ | 908 Devices Inc. | $11.65 | +1.39% | 284K | $481.54M |
| PHAT | NASDAQ | Phathom Pharmaceuticals, Inc. | $5.94 | +3.48% | 2.1M | $480.55M |
| CERS | NASDAQ | Cerus Corporation | $2.37 | +1.72% | 982K | $477.61M |
| BLSM | NASDAQ | BlossomHill Therapeutics, Inc. | $16.39 | +12.03% | 204K | $476.64M |
| SSII | NASDAQ | SS Innovations International, Inc. | $2.37 | +5.57% | 98K | $475.13M |
50 Healthcare Companies
Review companies currently returned for the Healthcare screen, with price, performance, volume and market-cap context.
How This Sector Screen Works
Results are loaded from current company data and can be narrowed by exchange or company search without changing the canonical sector page.
About the Healthcare Sector
The Healthcare classification groups companies with related business activities so investors can compare peers within a common market segment.
Related Sector Screens
Return to the screener directory to compare this sector with daily movers and the other industry groups covered by Cashu Finance.